TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/18/24 16:11 | 12/16/24 | CADL | Candel Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 1 | P | 7,500 | 6.00 | 0 | 1,250 | 43 | 4,127 | I | ||||||||||||||
11/26/24 16:15 | 11/22/24 | VRCA | Verrica Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | 1 | 1 | P.d | 0 | 0.00 | 0 | 22,921 | 151 | 38,061 | M | ||||||||||||||
9/16/24 16:05 | 9/12/24 | LQDA | Liquidia Corp | DE | Health | Drug | Pharmaceutical Preparations | 1 | 2 | P | 5,000 | 8.11 | 0 | 616 | 10 | 6,603 | I | ||||||||||||||
7/1/24 08:00 | 6/27/24 | TSHA | Taysha Gene Therapies, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | 1 | 2 | P | 3,163 | 2.21 | 0 | 1,433 | 6 | 24,851 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |